To investigate possible non genomic mechanisms mediating testosterone (T) induced relaxation in human corpus cavernosum tissue.
INTRODUCTION AND OBJECTIVES:
To investigate possible non genomic mechanisms mediating testosterone (T) induced relaxation in human corpus cavernosum tissue.
METHODS: Human corpus cavernosum tissue samples were obtained after consent from men undergoing penile prosthesis implantation (n[46) for tissue strip contractility experiments. After precontraction with phenylephrine 10-5 we administered increasing doses of T. DHT, and androstenedione up to a maximum of 300 microM. Blockade of hydrogen sulfide and nitric oxide biosynthesis was studied. Fifteen minutes after addition of the different compounds, tissue relaxation was measured. Results are expressed as meanAESD. Statistical analysis was performed using unpaired t-test. All procedures and use of tissues were approved by the local ethical review board.
RESULTS: At maximum concentration T relaxed precontracted tissues with 70.7 AE 16.9 % (p [ 0.003) compared to DMSO vehicle only. Androstenedione (p [ 0.17) and DHT (p[0.09) resulted in no significant difference in relaxation compared to T. Response to T were not inhibited by N (G)-nitro-L-arginine methyl ester (p [ 0.16), betacyanoalanine (p [ 0.16), propargylglycine (p[0.34) and glibenclamide (p[0.73) .
CONCLUSIONS: Previous research has suggested that relaxation effect of T on smooth muscle is mediated through non genomic mechanisms. We have shown that within the T biosynthesis pathway, T as well as precursor and derivative compounds produce relaxation. Blockade of nitric oxide, and hydrogen sulfide biosynthesis did not change the effect of T on relaxation. Because the effect is only seen at supraphysiological concentrations of T, further research is needed to elucidate the nongenomic mechanism of action of T on human CC tissue.
Source of Funding: none

MP59-15 AGE INDUCED NITROSO-REDOX IMBALANCE IS ASSOCIATED WITH SUBCLINICAL HYPOGONADISM
John Lee*, Manish Kuchakulla, Himanshu Arora, Shathiyah Kulandavelu, Evert Gonzalez, Thomas Masterson, Joshua Hare, Ranjith Ramasamy, Miami, FL INTRODUCTION AND OBJECTIVES: The cause for agerelated changes in testosterone remains unclear. We hypothesized that increased nitroso-redox imbalance with aging could affect testosterone production.
METHODS: Using western blotting we assessed several markers of nitroso-redox imbalance (4-HNE, NT, 3-NT, and S-NO) in serum of S-nitrosoglutathione reductase knock out (GSNOR KO) mice that have increased nitroso-redox imbalance and compared these to wild type (WT) mice. We evaluated the impact of age-induced nitrosoredox imbalance on serum luteinizing hormone (LH) and testosterone (T) in WT mice at pre-pubertal (< 2months), middle-aged (2-6 months), and aged (>12 months) mice. Finally, we evaluated whether ascorbate, an antioxidant, can be used to reverse ageinduced nitroso-redox imbalance.
RESULTS: We identified 4-HNE as a reliable marker of nitrosoredox imbalance as evidenced by increased expression in serum of GSNOR KO mice compared with WT mice. We demonstrated that 4-HNE expression in serum increases in WT mice with aging ( Figure 1 ). We also identified that testosterone levels were similar in middle-aged and aged mice and as expected, were increased compared to pre-pubertal mice. Interestingly, we found that serum LH levels in aged (n[8) and middle-aged (n[5) mice were increased when compared to pre-pubertal mice (n[5) consistent with the phenotype of subclinical hypogonadism (Figure 2) . GSNOR KO mice treated with ascorbate for 5 weeks had reduced the expression of 4-HNE and increased serum T levels compared to untreated mice.
CONCLUSIONS: Increasing 4-HNE expression with age suggests that nitroso-redox imbalance is a possible mechanism for subclinical hypogonadism. Recognizing the relationship and etiology on a currently poorly understood classification of hypogonadism could be a paradigm shift in how age-related testosterone change is diagnosed and treated.
Source of Funding: None
MP59-16 RESPONSE OF ENDOMETRIUM TO TESTOSTERONE THERAPY IN TRANS MEN AND NON-BINARY PEOPLE UNDERGOING HYSTERECTOMY
Oliver Ralph*, Nikita Shroff, Nim Christopher, Chesham, United Kingdom; Ali Ahmed, Alison Berner, James Barrett, Ann Sandison, London, United Kingdom; David Ralph, Chesham, United Kingdom INTRODUCTION AND OBJECTIVES: Endometrial cancer is the 4th most common cancer in people assigned female at birth in the UK, affecting 9300 people per year. This may be preceded by the development of endometrial hyperplasia with atypia as a pre-malignant lesion. The literature suggests that up to 20% of endometrial carcinomas express the androgen receptor while others concluded that circulating blood levels of estrogens and testosterone are positively associated with an increased risk of endometrial cancer in postmenopausal women, although there is no evidence of causality. Given the prolonged exposure of trans men and non-binary people with a uterus to testosterone, historically there has been a concern that this may lead to development of hyperplasia and malignancy.
